Yulai Zhou
1266 Fu Jin Road
Changchun, 130021, China
Changchun, 130021, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Hypoxia adaptation mechanism in rats' peripheral auditory system in high altitude migration: a time series transcriptome analysis.
Journal: Scientific reports
Published: January 14, 2024
Correction: Long-chain polyunsaturated fatty acids and extensively hydrolyzed casein-induced browning in a Ucp-1 reporter mouse model of obesity.
Journal: Food & function
Published: October 23, 2023
Structure-Based Discovery and Optimization of Furo[3,2-c]pyridin-4(5H)-one Derivatives as Potent and Second Bromodomain (BD2)-Selective Bromo and Extra Terminal Domain (BET) Inhibitors.
Journal: Journal of medicinal chemistry
Published: March 25, 2022
Prognostic targets recognition of rectal adenocarcinoma based on transcriptomics.
Journal: Medicine
Published: September 10, 2020
NRF2 regulates the sensitivity of human NSCLC cells to cystine deprivation-induced ferroptosis via FOCAD-FAK signaling pathway.
Journal: Redox biology
Published: April 18, 2020
Ginsenoside Rh3 Inhibits Proliferation and Induces Apoptosis of Colorectal Cancer Cells.
Journal: Pharmacology
Published: June 03, 2019
Linifanib exerts dual anti-obesity effect by regulating adipocyte browning and formation.
Journal: Life sciences
Published: November 20, 2018
Application of induced pluripotent stem cell transplants: Autologous or allogeneic?
Journal: Life sciences
Published: August 12, 2018
Structure-Based Discovery and Optimization of Benzo[ d]isoxazole Derivatives as Potent and Selective BET Inhibitors for Potential Treatment of Castration-Resistant Prostate Cancer (CRPC).
Journal: Journal of medicinal chemistry
Published: March 24, 2018
Y08060: A Selective BET Inhibitor for Treatment of Prostate Cancer.
Journal: ACS medicinal chemistry letters
Published: January 03, 2018
Binding efficiency of recombinant collagen-binding basic fibroblast growth factors (CBD-bFGFs) and their promotion for NIH-3T3 cell proliferation.
Journal: Biopolymers
Published: October 08, 2017
Discovery and optimization of 1-(1H-indol-1-yl)ethanone derivatives as CBP/EP300 bromodomain inhibitors for the treatment of castration-resistant prostate cancer.
Journal: European journal of medicinal chemistry
Published: September 08, 2017
Last Updated: 09/26/2026